INDSWIFT LABORATORIES
Back to Cashflow Statement
|
INDSWIFT LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹142 Cr | ₹72 Cr | ₹681 Cr | ₹-186 Cr | ₹-141 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDSWIFT LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹142 Cr |
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹681 Cr |
| Mar2023 | ₹-186 Cr |
| Mar2022 | ₹-141 Cr |
How is Cash Flow from Financing Activities of INDSWIFT LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹142 Cr | 95.81 | |
| Mar2025 | ₹72 Cr | -89.36 | |
| Mar2024 | ₹681 Cr | Positive | |
| Mar2023 | ₹-186 Cr | Negative | |
| Mar2022 | ₹-141 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹3,072.8 Cr | -1.9% | -11.1% | 247.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -1.9% |
-11.1% |
247.2% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses